Andrea Lampis

15 Cotswold Rd
Sutton Upon Derwent, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

IDH1 R132 mutations or HER2-positivity and benefit from platinum-based therapy for biliary tract cancers.

IDH1 R132 mutations or HER2-positivity and benefit from platinum-based therapy for biliary tract cancers.

Journal: JHEP reports : innovation in hepatology

Published: December 13, 2025

Density-adjusted analysis of cell interactions to decipher tissue landscape changes.

Density-adjusted analysis of cell interactions to decipher tissue landscape changes.

Journal: iScience

Published: May 07, 2025

Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line Chemotherapy.

Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line Chemotherapy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 30, 2024

Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer.

Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 16, 2023

Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer.

Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer.

Journal: Nature cancer

Published: September 13, 2023

MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patients.

MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patients.

Journal: Frontiers in oncology

Published: July 13, 2023

NTRK fusions in colorectal cancer: clinical meaning and future perspective.

NTRK fusions in colorectal cancer: clinical meaning and future perspective.

Journal: Expert opinion on therapeutic targets

Published: September 07, 2021

Challenges and perspectives for immunotherapy in oesophageal cancer: A look to the future (Review).

Challenges and perspectives for immunotherapy in oesophageal cancer: A look to the future (Review).

Journal: International journal of molecular medicine

Published: December 21, 2020

Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer.

Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer.

Journal: Genes

Published: November 24, 2020

MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer.

MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer.

Journal: Cell death and differentiation

Published: October 13, 2020

Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage.

Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage.

Journal: Nature communications

Published: October 06, 2020

EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers.

EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers.

Journal: Gut

Published: July 28, 2020

Showing 1-12 of 40

Last Updated: 09/26/2026